Presentation Information

[F2-126]Modulating the immune cell fate with in vivo reprogramming technologies

*Yasuhiro Yamada1 (1. Graduate School of Medicine, The University of Tokyo (Japan))

Login required to view


Comment

To browse or post comments, you must log in.Log in